ENSAYO PARA LA DETERMINACIÓN CUALITATIVA DE ANTICUERPOS PARA EL VIRUS DE INMUNODEFICIENCIA HUMANA TIPO 1/O/2
Mexico·Clase II·III. Agentes de
diagnóstico·SIEMENS HEALTHCARE
DIAGNOSTICS, S. DE R.L. DE
C.V.·Registered April 17, 2024- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- ATELLICA IM HIV 1/O/2 ENHANCED (EHIV)
- Trade Name (English)
- ATELLICA IM HIV 1/O/2 ENHANCED (EHIV)
- Analysis ID
- 1098R2024 SSA
- Registration Date
- April 17, 2024
- Name (Spanish)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.
- Name (English)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.
Access comprehensive regulatory information for ENSAYO PARA LA DETERMINACIÓN CUALITATIVA DE ANTICUERPOS PARA EL VIRUS DE INMUNODEFICIENCIA HUMANA TIPO 1/O/2 (ENSAYO PARA LA DETERMINACIÓN CUALITATIVA DE ANTICUERPOS PARA EL VIRUS DE INMUNODEFICIENCIA HUMANA TIPO 1/O/2) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1098R2024 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.. The device was registered on April 17, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.